Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ardenia Investments LtdfiledCriticalArdenia Investments Ltd
Priority to MYPI20034101priorityCriticalpatent/MY136047A/en
Publication of MY136047ApublicationCriticalpatent/MY136047A/en
THIS INVENTION RELATES TO NOVEL COMPOUNDS, CAPABLE OF POLENTIATING THE EFFICACY OF THERAPEUTICALLY ACTIVE COMPOUNDS, FOR EXAMPLE CYTOTOXIC COMPOUNDS USED IN THE TREATMENT OF CANCER. THE NOVEL COMPOUNDS HAVE BEEN SHOWN TO INCREASE THE PHARMACOLOGICAL ACTIVITY OF A CONVENTIONAL PACLITAXEL FORMULATION AND TO MAKE IT POSSIBLE TO MANUFACTURE A NEW FORMULATION OF PACLITAXEL EXHIBITING IMPROVED SOLUBILITY, IMPROVED STORAGE PROPERTIES, AND INCREASED THERAPEUTIC EFFICACY AS SHOWN IN THE ENCLOSED EXAMPLES. (FORMULA I,II,III,IV,V,VI)